Intercept Pharmaceuticals (ICPT) PT Lowered to $170 at Oppenheimer
Tweet
Share
E-mail
Get Alerts ICPT Hot Sheet
Price: $19.00 --0%
Rating Summary:
13 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
13 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Oppenheimer analyst Jay Olson lowered the price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $170.00 (from $175.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- Visual Photonics Epitaxy Co Ltd (2455:TT) PT Raised to NT$846 at Macquarie
- Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
